Acquisitions11 Dec 2025, 10:45 am
Eiko Lifesciences to Acquire 51% Stake in SSM Formulations for INR 18 Cr, to Issue Warrants & Equity Shares
AI Summary
Eiko Lifesciences Ltd announced that its Board approved the acquisition of 51% equity shares of M/s. SSM Formulations Private Limited, a company operating in the pharmaceuticals business, for a total consideration of INR 18,00,00,000. Post-acquisition, SSM Formulations will become a subsidiary company of Eiko LifeSciences Limited. The company will also raise funds through the issue and allotment of up to 33,00,000 warrants and up to 6,75,000 equity shares on a preferential basis. The draft notice of the Extra Ordinary General Meeting has been approved to seek necessary approval from the members of the company.
Key Highlights
- Eiko Lifesciences to acquire 51% stake in SSM Formulations for INR 18 Cr
- SSM Formulations to become a subsidiary of Eiko LifeSciences Limited
- Raising funds through the issuance of warrants and equity shares
- Total warrants to be issued: 33,00,000
- Total equity shares to be issued: 6,75,000